Introduction {#s1}
============

Translation initiation of eukaryotic mRNA generally follows the scanning mechanism, which starts with the attachment of an activated 40S ribosomal subunit (43S preinitiation complex; PIC) to the cap structure of mRNA (forming the 48S-PIC), and the movement of the resulting complex along the 5′ UTR of mRNA to locate the initiation codon (TIS, generally AUG). This process directly depends on the extent to which a particular mRNA recruits the PIC, but also on the degree of RNA secondary structure (classical dsRNA and G-quadruplexes) found in its 5′ UTR ([@bib18]; [@bib19]; [@bib24]; [@bib38]; [@bib41]; [@bib42]). To locate the TIS, the 48S-PIC must inspect the mRNA sequence codon-by-codon in the decoding groove of 40S neck (also known as the mRNA channel), which includes P and A sites for aminoacyl-tRNA binding. Thus, mRNA molecules must enter the channel in a single-stranded form, which requires prior unwinding by the RNA helicases associated with the 48S-PIC.

eIF4A is the main helicase that removes local secondary structure by alternating cycles of binding and dissociation from the mRNA during the scanning process ([@bib41]; [@bib47]; [@bib50]). eIF4A binds eIF4G to form the eIF4F complex together with eIF4E, which collectively promotes activation of the mRNA, recruitment of the PIC and the scanning process ([@bib14]; [@bib39]; [@bib43]; [@bib47]). Recently, other RNA helicases such as yeast Ded-1 (and perhaps its mammalian ortholog DDX-3), DHX-29, DHX-36 and DHX-9 have been reported to assist in the RNA unwinding and scanning of specific mRNA subsets ([@bib13]; [@bib15]; [@bib16]; [@bib38]; [@bib46]). It is thought that eIF4F binding to the cap removes the eventual secondary structure near the 5′ extreme of the mRNA (activation) to favor recruitment of the PIC. Recent data support the notion that mRNA is threaded into the channel from the solvent side of the 40S subunit through a chain of cooperative interactions involving eIF4E-eIF4G-eIF3-40S ([@bib25]). The scaffold protein eIF4G can bind both eIF3 (as part of the PIC) and the 40S subunit itself near the feet of the solvent side, thus promoting the attachment of PIC to mRNA ([@bib27]; [@bib58]; [@bib62]). However, little is known about the topology of the 48S-PIC, in part because its presumably dynamic nature has limited the use of cryo-EM reconstruction, which has successfully resolved more stable complexes including the PIC ([@bib10]; [@bib17]; [@bib33]). Recently, the helicase eIF4A has been located bound to alphaviral mRNA on the solvent side of the 48S-PIC assembled in vitro ([@bib53]). This would support a scanning complex model in which eIF4A is placed at the leading edge of the 40S subunit, thus 'pulling' the complex forward as it advances along the mRNA ([@bib33]; [@bib53]). This model would also explain the greater dependence on eIF4A activity of mRNAs that have structured or long 5′ UTRs, many of which are involved in cell-cycle regulation and proliferation ([@bib36]; [@bib48]; [@bib60]). For this reason, natural inhibitors of eIF4A are currently being tested as anti-cancer drugs ([@bib5]).

The existence of RNA extensions such as ES6S and ES3S protruding from the solvent side of the 40S body, specifically in mammals, has been interpreted as a platform to recruit eIFs and other ligands, as described recently for ES27L of the 60S subunit ([@bib11]; [@bib23]), although direct support for this idea has not yet been presented. The ES6S region is composed of four RNA helices near the feet of the 40S particle, which form a bundle of tentacle-like structures ([@bib3]; [@bib30]; [@bib34]). Two of these helices (ES6S^A^ and ES6S^B^) project outward from the ribosome body, and comparative analysis of the 40S particle alone and in PIC or 80S complexes suggested that these helices can undergo some degree of conformational change ([@bib34]; [@bib51]). Moreover, because scanning is a unique capability of 40S that is not present in the bacterial 30S subunit, ES6S has been proposed to participate in the scanning process, at least for some viral mRNAs ([@bib52]). The existence of a conserved pattern of ES6S rRNA sequence complementary with eukaryotic mRNA 5′ UTRs also suggested a role for the ES6S region in mRNA loading onto PIC ([@bib40]).

In previous studies, we detected the interaction of AUG-downstream nucleotides of alphaviral mRNAs with the ES6S region of the 40S ribosomal subunit ([@bib51]). These viral mRNAs contain a highly stable RNA stem-loop structure (DLP) located 27--31 nt downstream of the AUG, so we were able to snapshot the eIF4A helicase bound to mRNA in 48S PICs assembled in vitro. In this work, we studied the role of ES6S in genome-wide scanning process by the 48S PIC using a combination of structural and functional analyses.

Results {#s2}
=======

The path of mRNA through the ES6S region of the 48S PIC {#s2-1}
-------------------------------------------------------

To explore the possibility that ES6S could represent a universal region of the 48S-PIC in which mRNA enters and unwinds, we systematically identified the contacts of mRNA with the 18S rRNA and 40S ribosomal proteins (RPSs) that are in or near ES6S region. To this end, we designed a synthetic 128-nt mRNA (unstructured) bearing a short (19 nt) 5′ UTR, a 3′ poly(A) tail and minimal secondary structure ([Figure 1](#fig1){ref-type="fig"}, see also [Supplementary file 1](#supp1){ref-type="supplementary-material"} for details). On the basis of previous observations with alphaviral mRNA, we introduced photo-activatable 4-thio-UTPs (4-thio-U) at positions +24, +27, +31 and +34 (downstream of the AUG) as described previously ([Figure 1a](#fig1){ref-type="fig"}). Sites that crosslink this mRNA with 18S rRNA were identified by reverse transcriptase termination site (RTTS) assay and RNA-seq ([@bib21]) ([Figure 1a](#fig1){ref-type="fig"}, left panel), which provided much higher sensitivity and coverage than the classical electrophoretic resolution in urea-polyacrylamide gels ([@bib51]). We included GMP-PNP in the assays to restrict the analysis to those interactions that occurred within the 48S-PIC. The vast majority of specific crosslinking sites mapped to within the nt 700--910 region of 18S RNA, concentrating in the ES6S^E^ (nt 865--910), ES6S^C--D^ (nt 795--864), ES6S^B^ (nt 740--793) and ES6S^A^ (nt 681--735) helices ([Figure 1a](#fig1){ref-type="fig"}). No crosslinking with the inner residues of 18S rRNA was detected, indicating that mRNA contacted only surface-exposed regions. We found abundant contacts not only with the projected parts of ES6S, but also with residues that are at the base of these helices (e.g. residues 802--803 of helix C), embedded in the protein--RNA layer of the 40S body ([Figure 1a](#fig1){ref-type="fig"}). This allowed us to draw an mRNA path through the ES6S region that extends from ES6S^E^ to the distal loop of ES6S^C--D^, including the ES6S^B^ and ES6S^A^ helices, and that is flanked by ribosomal proteins such as eS7, eS4 and uS4 ([Figure 1a](#fig1){ref-type="fig"}). In a parallel experiment, we also included a previously characterized mRNA based on the Semliki Forest virus (SFV) genome, which contains a single 4-thio-U at the 5′ flank (+27) of the DLP ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). SFV-DLP n27 mRNA generated a crosslinking pattern that is similar, though not identical, to that observed for unstructured mRNA. Specifically, the number of crosslinks to residues of the ES6S^E^ and ES6S^C-D^ helices increased in SFV-DLP n27 mRNA compared to unstructured mRNA ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

![Identification of mRNA contacts with 18S rRNA and ribosomal proteins (RPSs) on the solvent side of the 48S-PIC.\
(**a**) Schematic diagram representing the method used to identify mRNA-18S rRNA contacts by specific crosslinking of 4-thio-U, followed by reverse transcriptase termination site (RTTS) assay and next-generation sequencing (NGS) (left panel). The middle and right panels show two solvent-side views of rabbit 40S (PDB: 4KZZ) that include the classical mRNA entry channel and the ES6S region. The positions of 4-thio-U residues in unstructured mRNA used for 48S PIC assembly are indicated, with the 18 most abundant crosslinking sites detected in 18S rRNA marked in red (see also [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"} for further details). Residues that have been reported to crosslink with eIF4G ([@bib62]) are marked in green. uS5 (formerly RPS2) and eS4 (formerly RPS4X) are marked in brown, whereas the rest of the RPSs are shown in light blue. Note that, in this model, the ES6S^A^ helix is in an 'inward' orientation towards the eIF3b. (**b**) Identification of RPSs that crosslink with unstructured mRNA assembled into the 48S PIC. Protein--mRNA interactions were captured throughout the mRNA (left panel); the 40 most-represented hits are shown in the right panel. Proteins marked in blue and black are those located on the solvent side and on the 60S subunit side, respectively. Note that uS5 was the hit with the highest representation.](elife-48246-fig1){#fig1}

Since the region that extends between ES6S and the classical mRNA entry channel contains no exposed 18S rRNA, a proteomic analysis of RPSs that could contact the mRNA in this region was performed. Attempts to detect proteins that are crosslinked to single 4-thio-U residues of mRNA by mass spectrometry (MS) failed, so unlabeled unstructured and SFV-DLP n27 mRNAs were used to assemble 48S-PICs that were subsequently crosslinked under a 254 nm lamp to detect RNA--protein contacts along the entire mRNA path. A similar pattern of crosslinked RPSs was observed for both mRNAs, with uS5 (formerly RPS2) the hit with the highest score and coverage ([Figure 1b](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Crosslinking of uS5 at +11 nt downstream of the AUG has been previously reported in 48S-PICs assembled in vitro using a synthetic mRNA and purified 40S subunits and eIFs ([@bib45]). Interestingly, uS5 was localized between the mRNA entry channel and the ES6S region of the 40S subunit, extending about 48 Å along the channel ([Figure 1a](#fig1){ref-type="fig"}). We also detected other crosslinked RPSs with lower scores, including some that were located either on the solvent side of the 40S subunit (uS3, uS4, eS4, eS6 and eS24), or on the intersubunit side near the decoding site (eS19) and at the mRNA exit channel (uS17).

In previous reports, we found that both eIF4A and eIF3g could be crosslinked with alphaviral mRNAs bearing the DLP structure ([@bib53]). Thus, we compared the crosslinking patterns generated by unstructured mRNAs, which lacks secondary structure, and SFV-DLP mRNAs labeled with \[α-^32^P\] and 4-thio-U after assembly into the 48S-PIC. Owing to their similar apparent molecular weight, eIF4A and eIF3g protein bands migrated as a doublet in SDS-PAGE ([@bib53]). Both eIF4A and eIF3g bands were crosslinked with SFV-DLP n27 mRNA to a similar extent, whereas unstructured mRNA generated strong crosslinking with eIF3g and little (if any) with eIF4A ([Figure 2a](#fig2){ref-type="fig"}). This was confirmed by denaturing immunoprecipitation (dIP) experiments with specific antibodies ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The fact that unstructured mRNA generated no crosslinking with eIF4A is consistent with previous data showing the critical role of DLP structure in the trapping of eIF4A within the 48S-PIC ([@bib53]). To map the placement of eIF4A in the 48S PIC more precisely, we systematically changed the position of 4-thio-U along the AUG-DLP stretch of SFV-DLP n27 mRNA ([Figure 2b](#fig2){ref-type="fig"}). Maximum crosslinking with eIF3g was observed when 4-thio-U was placed +24 nt downstream of the AUG, whereas maximum crosslinking of eIF4A was achieved when 4-thio-U was placed at +27 nt. By modeling mRNA placement throughout the ES6S region of the 48S-PIC ([@bib53]), we found that crosslinking of eIF3g at position +24 fit well with the suggested placement of eIF3g bound to eIF3b near ES6S^A^ ([@bib7]; [@bib9]; [@bib17]). According to our data, eIF4A may be placed a bit further downstream, probably between the ES6S^A^ and ES6S^B^ helices ([Figure 2c](#fig2){ref-type="fig"}).

![Identification of eIFs associated with mRNA in the ES6S region.\
(**a**) Patterns of protein crosslinking generated with the indicated mRNAs, which are labeled with 4-thio-U and \[α-^32^P\]-GTP. The identified protein bands are indicated, with a relative quantification of the intensity of the protein bands shown below, according to this experiment and the one shown in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**b**) Mapping of the interaction of eIF4A and eIF3g with mRNA in the ES6S region. SFV-DLP mRNAs with a single 4-thio-U placed at the indicated positions were used to assemble the 48S-PIC, and the pattern of protein crosslinking was analyzed. (**c**) The positions of mRNA that crosslinked with eIF4A and eIF3g were projected on the solvent side of the PIC, assuming that the mRNA is threaded along the ES6S region. The +11 position of mRNA is placed at the mRNA entry channel ([@bib30]; [@bib45]). A rise per base of 4.5 Å for a stretched RNA strand was used as described previously ([@bib51]).](elife-48246-fig2){#fig2}

ES6S blockage inhibits translation initiation {#s2-2}
---------------------------------------------

The high copy number of rDNA genes in eukaryotic genomes makes it impossible to determine the role of the ES6S region in translation using classical genetic disruption approaches. Therefore, we decided to block ES6S by means of specific oligos targeting 18S rRNA, or by fusing RPSs surrounding the ES6S region to proteins that could sterically block this region. From among all the oligos tested, we selected oligo 4, which targets a partially single-stranded sequence in ES6S^D^ that showed some inhibitory effects on translation of alphavirus mRNA ([@bib51]). We determined the 3′ effective pairings of oligo 4 with ES6S^D^ on native 40S particles by RNAse H assay, which allowed us to construct models of oligo 4 bound to the 40S particle ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). In all of these models, the 5′ extreme of oligo 4 is likely to be projected towards an open cavity that is delimited by ES6S^B^, ES6S^A^, uS19, uS4 and the C-terminus of eS4 ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We also conjugated fluorophores such as VIC, Texas Red (TR) and Fluorescein (FITC) to the 5′ end of oligo 4 to increase its blocking capacity and to facilitate its detection ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). First, we found the conditions for optimal oligo delivery into cells, which maximized transfection efficiency and reduced oligo aggregation, to increase its bioavailability ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). We transfected human (HEK293T, HeLa) and murine (MEF) cells with 70--90% efficiency. To confirm that oligo 4 bound to 18S rRNA properly in transfected cells, we carried out an 'in situ' RT-PCR amplification using the endogenous bound oligo 4 to prime retrotranscription of 18S rRNA isolated from transfected cells. PCR amplification of the resulting cDNA revealed that oligo 4 was bound to both 40S and 80S fractions ([Figure 3a](#fig3){ref-type="fig"}, lower right panel). Next, we analyzed the effect of VIC-oligo 4 on general translation by means of metabolic labeling with \[^35^S\]-Met. Transfection of MEFs with VIC-oligo 4, but not with its unconjugated form, strongly inhibited protein synthesis at 12 hr post-transfection (hpt) ([Figure 3b](#fig3){ref-type="fig"}, upper left panel). In these experiments, we also included oligo 5.4 (both VIC-conjugated and unconjugated), which targets helix ES6S^B^ ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) without significantly affecting translation, showing that the effect of VIC-oligo 4 was specific.

To test the role of the fluorochrome in the inhibitory activity of VIC-oligo 4, we replaced VIC with FITC or TR ([Figure 3b](#fig3){ref-type="fig"}, upper left panel), finding a similar degree of translation inhibition for all of the fluorochromes tested. This suggests that the inclusion of an additional mass at the 5′ end was responsible for the inhibitory activity of oligo 4 on translation. The effect of VIC-oligo 4 on translation was rapid, starting at 4--6 hpt and reaching a maximum at 8 hpt ([Figure 3b](#fig3){ref-type="fig"}, upper right panel), suggesting a direct impact on translation rather than an indirect consequence of cell growth arrest that was induced by VIC-oligo 4 some time after post-transfection ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Analysis of polysome profiles at 6--8 hpt revealed the accumulation of 80S (monosomes) together with a decrease in heavy polysomes, strongly suggesting a blockade of the initiation step of protein synthesis ([Figure 3b](#fig3){ref-type="fig"}, lower panel). We did not detect significant alteration in the 28S/18S ratio at different times post-transfection, nor alteration in the distribution of representative RPSs across the sucrose gradient, suggesting that 40S biogenesis was not significantly altered by the oligo ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}).

![ES6S blockage affects global translation.\
(**a**) Binding site of oligonucleotides 4 (red) and 5.4 (blue) in the ES6S region of the 40S subunit (left panel). Note that in this model of PIC (EMD-5658), the ES6S^A^ helix is in an 'outward' orientation. Right panels show VIC-oligo 4 uptake and binding to ES6S^D^. The upper panel shows fluorescence microscopy of VIC-oligo 4 (green) combined with an IF staining of eS7 (red) and DAPI (blue) in MEF cells. Note the typical aggregation of the oligo inside the cells. The bottom panel shows an in situ RT-PCR of RNA extracted from the indicated fractions. cDNA was primed exclusively by the VIC-oligo 4, which remained bound to ES6S^D^ during RNA extraction. Total RNA from untransfected cells was included as a negative control. (**b**) Metabolic labeling of MEF cells with \[^35^S\]-Met. Cells transfected with the indicated oligonucleotides were labeled for 30 min at 12 hr post-transfection (hpt), and analyzed by SDS-PAGE and autoradiography. A SYPRO staining of the middle part of gels is shown as loading control (--). The upper right panel shows a time-course analysis of the VIC-oligo 4 effect on translation. The lower panel shows a polysome profile of MEFs transfected with VIC-oligo 4 (red) or with unconjugated oligo 4 (black). Extracts were separated in a 10--40% sucrose gradient and fractionated as described in the Materials and methods; the identities of the main peaks are indicated. (**c**) Fusion protein-mediated blockage of ES6S affects global translation. Model of EGFP (green) fused to eS4 (orange) of the 40S subunit. Note that in this model of human 40S, the ES6S^A^ helix is in an 'outward' orientation (upper left panel). Fluorescence microscopy of HeLa cells expressing eS4--EGFP fusion protein (upper right panel). Micrographs were taken at 36 h. Nuclei are encircled by a dashed line; note the bright nucleolar and cytoplasmic staining. The bottom panel shows the distribution of eS4 and eS4-EGFP proteins in a 10--35% sucrose gradient from HEK293T cells transfected with eS4-EGFP. (**d**) Measurement of total protein synthesis by OPP fluorescence in transfected cells expressing no/low (black line) or high levels of eS4-EGFP (green line). Cells were first gated into two groups according to EGFP expression, and then the distribution of OPP fluorescence intensity was determined (left panel). The right panel shows OPP fluorescence measurements for cells transfected with eS4 alone, cells treated with 50 μg/ml CHX for 20 min, and cells transfected with eS4--EGFP that express (or do not express) EGFP. Data are the mean of three independent experiments ± standard deviations (SD).](elife-48246-fig3){#fig3}

Next, we tested the effect of VIC--oligo 4 on protein crosslinking with mRNA within the 48S complex. As shown in [Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}, ES6S blockage by VIC--oligo 4 drastically reduced eIF4A/eIF3g crosslinking, suggesting that VIC--oligo 4 disturbed the interaction of mRNAs with ES6S region.

We then aimed to block ES6S by fusion of heterologous polypeptides to some surrounding RPSs. Among the proteins that are located within or near the ES6S region, we selected eS4 (formerly RPS4X) as a candidate. The C-terminus of eS4 projects nearly perpendicular to the major axis of the 40S particle between ES6S^A^ and ES6S^D^, offering a place for the fusion of polypeptides of increasing sizes. Plasmids encoding recombinant eS4 fused to different polypeptides were transfected into HEK293T and HeLa cells, and their expression, incorporation into 40S particles and effect on translation were analyzed. Among the constructs tested, eS4 fused to EGFP was the one that gave the most consistent results. When eS4--EGFP in the 40S particle was modeled, the EGFP mass could be easily placed between ES6S^B^ and ES6S^C-D^, occupying a significant volume (28.67 × 10^3^ Å^3^) ([Figure 3c](#fig3){ref-type="fig"}, upper right panel).

Overexpressed eS4--EGFP accumulated in the nucleolus, but also in the cytoplasm of transfected cells ([Figure 3c](#fig3){ref-type="fig"}, upper right panel), as previously reported for other overexpressed RPSs ([@bib2]). Comparison of the distribution of endogenous eS4 and eS4--EGFP in sucrose gradients confirmed that eS4--EGFP was incorporated into 40S and 80S particles with the same efficiency as eS4 ([Figure 3c](#fig3){ref-type="fig"}, lower panel). However, we found a differential increase in the 40S accumulation of eS4--EGFP when compared to that of endogenous eS4, suggesting a block in the pre-initiation step. The effect of eS4--EGFP overexpression on protein synthesis was measured by O-propargyl-puromycin (OPP) incorporation followed by fluorescent quantification of the cells expressing EGFP (or not). Clearly, protein synthesis was blocked by eS4--EGFP, to an extent comparable to that resulting from cycloheximide treatment ([Figure 3d](#fig3){ref-type="fig"}). To test whether the incorporation of eS4--EGFP into the 40S particle affected the binding of some eIF3 subunits (such as eIF3g, which binds eIF3b near ES6S^A^ of 40S), we probed sucrose gradients with different antibodies ([Figure 3---figure supplement 5](#fig3s5){ref-type="fig"}), finding no significant differences in the distributions of the analyzed eIFs.

ES6S blockage differentially affects scanning-dependent translation {#s2-3}
-------------------------------------------------------------------

ES6S may represent an mRNA-threading region for the unwinding of the RNA secondary structure that is necessary for scanning, so we evaluated the effect of VIC--oligo 4 on the translation of luciferase (luc) mRNAs bearing 5′ UTRs of different lengths (33--656 nt) and secondary structure (ΔG° from −5 to −70 kcal.mol^−1^) ([Figure 4a](#fig4){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). MEFs were cotransfected with luc plasmids and VIC--oligo 4, and luc activity was measured at 14 hpt. VIC--oligo 4 transfection reduced the accumulation of luc in all cases, but the extent of inhibition dramatically differed among the constructions tested. Translation of luc mRNAs bearing a long 5′ UTR (656 nt) or an average-sized 5′ UTR (121 nt) with a stable stem-loop structure (SL20) was dramatically impaired by VIC--oligo 4 transfection (50--80-fold inhibition) ([Figure 4a](#fig4){ref-type="fig"}). By contrast, translation of luc mRNA bearing a short 5′ UTR (33 nt) was much less affected by VIC--oligo 4 transfection (about two-fold inhibition). We further confirmed that sensitivity to VIC--oligo-4-induced translational block increased with the 5′ UTR length of the mRNA ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We also tested the effect of VIC--oligo 4 on hepatitis C virus (HCV) IRES-driven translation, showing only a modest effect (2--3 fold inhibition), similar to that observed for mRNA with a short 5′ UTR ([Figure 4a](#fig4){ref-type="fig"}). To further confirm this differential effect on cap-dependent and IRES-driven translation, we tested the effect of VIC--oligo 4 on the translation of other viral mRNAs. Cells were first transfected with VIC--oligo 4, and then infected with SFV or vesicular stomatitis virus (VSV) as prototypes of cap-dependent translation, and encephalomyocarditis virus (EMC) or poliovirus (PV) as prototypes of IRES-driven translation. Accumulation of EMC or PV proteins was not significantly affected by VIC--oligo 4 transfection when compared with controls, whereas translation of SFV and VSV proteins was dramatically inhibited by VIC--oligo 4 ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

![Differential effect of ES6S blockage on cap-dependent translation.\
(**a**) Schematic diagram of luc mRNAs bearing different 5′ UTRs (details in [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Note that the cap-proximal sequences are identical for the 63, 656 and SL20 mRNAs (denoted with a black line). HCV, hepatitis C virus. MEF cells were cotransfected with 1 μg of the indicated luc plasmid and 10 pmol of VIC--oligo 4; transfections with oligo 4 and VIC--oligo capsid did not significantly affect luc expression, and are included as controls. Data are expressed as fold inhibition with respect to oligo 4 control from four independent experiments (mean ± SD). (**b**) Effect of VIC-oligo 4 on translation of viral mRNAs. MEFs were transfected with the indicated oligonucleotides and infected 6 hr later with the indicated viruses at a multiplicity of infection (MOI) of 10 pfu/cell. At 4 hr post-infection, cells were metabolically labeled with \[^35^S\]-Met for 30 min and analyzed as described in the Materials and methods. The positions of the main viral protein bands are indicated. (**c**) Effect of VIC--oligo 4 on luc translation driven by the 5′ UTR of ATF-4 mRNA. MEFs constitutively expressing 5′ UTR ATF-4--Luc mRNA were transfected with the indicated oligonucleotides, and treated 6 hr later with 2 μM thapsigargin for the indicated times.](elife-48246-fig4){#fig4}

As translation of ATF-4 mRNA upon stress-induced eIF2α phosphorylation is a paradigm of scanning-dependent reinitiation on downstream bona fide ATG, we tested the effect of VIC--oligo 4 on the translation of luciferase mRNA driven by the 5′ UTR of human ATF-4 mRNA. Under normal conditions, 40S initiates from the regulatory uORF1 and uORF2 in the 5′ UTR of ATF-4 mRNA, leading to constitutive translational repression that is relieved when the availability of ternary complex is reduced by eIF2α phosphorylation ([@bib55]). Clearly, VIC--oligo 4 transfection of MEFs expressing the 5′ UTR ATF-4 Luc mRNA prevented the accumulation of luc upon thapsigargin treatment, showing that VIC--oligo 4 did indeed block scanning and/or reinitiation on the 5′ UTR ATF-4 mRNA ([Figure 4c](#fig4){ref-type="fig"}).

Genome-wide analysis reveals the role of the ES6S region in the translation of mRNAs with G-rich 5′ UTRs {#s2-4}
--------------------------------------------------------------------------------------------------------

To test the effect of VIC--oligo 4 on genome-wide mRNA translation, we carried out polysome profiling in HEK293T cells ([Figure 5a](#fig5){ref-type="fig"}). After transfection with oligo 4 or VIC--oligo 4, mRNA levels were quantified in monosomal (M) and polysomal (P) fractions ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). The P/M ratio faithfully represents the translation efficiency (TE) of a given mRNA, as we previously reported ([@bib57]). For each gene, the oligo 4/VIC--oligo 4 TE ratio was determined and expressed as log~2 ~fold change (FC TE), with those \>1 considered to be downregulated ('TE down'; n = 1054) and those \<−0.7 considered to be upregulated ('TE up'; n = 333). We found that the sensitivity of transcriptome-wide mRNAs to VIC--oligo 4 varied more than 30-fold, although the distribution of TE change was clearly skewed towards translation inhibition ([Figure 5a](#fig5){ref-type="fig"}). Very small differences in total mRNA abundance were found when comparing cells transfected with oligo 4 and VIC--oligo 4 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Gene ontology (GO) analysis revealed that the 'TE down' group was enriched in mRNAs that are involved in cell signaling and growth, especially in the G-protein-coupled receptor signaling and Ras pathways ([Figure 5b](#fig5){ref-type="fig"}). This group was also enriched in KEGG pathway mRNAs related to cancer and other diseases ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). On the other hand, the 'TE up' group was highly enriched in GO terms related to RNA metabolism, including mRNA splicing, rRNA processing and mRNA translation ([Figure 5b](#fig5){ref-type="fig"}). Accordingly, the TE down group was enriched in mRNAs encoding membrane proteins and under-represented in mRNAs encoding nuclear proteins that have RNA binding or ligase activities ([Figure 5b](#fig5){ref-type="fig"}, lower panel).

Next, we compared some basic features of the 5′ UTR mRNA among TE groups. Principal component analysis (PCA) confirmed that 5′ UTR length, G+C composition and RNA secondary structure content were the parameters that most contributed to the variance ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). We found that the G+C content and the propensity to fold into secondary structures (RNAfold, ΔG°) were the 5′ UTR features that best correlated with TE groups. 5′ UTRs of the 'TE down' group showed a higher G+C content than those of the 'TE up' group (74% *vs* 62.96%, p=3×10^−49^, U test), and a more stable predicted RNA secondary structure (−72.50 kcal.mol^−1^ *vs* −27.7 kcal.mol^−1^, p=3×10^−23^, U test) ([Figure 5c](#fig5){ref-type="fig"}). The 5′ UTRs of the 'TE down' group were also larger than those of the 'TE up' group (p=6×10^−12^, U test) ([Figure 5c](#fig5){ref-type="fig"}). Next, we used the MEME algorithm to search for short motif enrichment in the \'TE down\' and \'TE up\' groups of mRNAs. Interestingly, we found a strong enrichment of 15-mer and 12-mer (GGC/A)~4~ motifs (E-value = 2.7×10^−76^ and 2.7 × 10^−47^, respectively) in the 'TE down' group that was not detected in the 'TE up' group ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). As (GGC/A)~4~ motifs can fold into G-quadruplexes (G4s) ([@bib60]), we carried out a systematic research of the classical G4 motif in our dataset using the QuadBase2 program ([@bib8]). A strong enrichment of the (G~3~N~1--12~)~4~ motif was found in the 5′ UTRs of the 'TE down' mRNAs (χ^2^ \< 10^−4^), being 3-fold higher than that found in the 'TE up' group. About 75% of 'TE down' mRNAs contained either 12-mer (GGC/A)~4~ or classical G4 ([Figure 5d](#fig5){ref-type="fig"}, upper left panel). To test the contribution of (GGC)~4~ and G4 motifs to the observed translation sensitivity to VIC--oligo 4, we cloned a single copy of either motif into the 5′ UTR of a pLuc plasmid. For G4, we tested three experimentally validated variants of the motif, including one 'perfect' G4 and two motifs that are present in human Bcl2 ([@bib49]) and TM3-MMP ([@bib37]) mRNAs ([Figure 5E](#fig5){ref-type="fig"}). Clearly, the presence of G4 motifs rendered the translation of luc mRNA more sensitive to VIC--oligo 4, whereas the presence of (GGC)~4~ had less of an effect. Moreover, we found a correlation between the predicted stability of the G4 motif and the extent of translation inhibition by VIC--oligo 4 ([Figure 5e](#fig5){ref-type="fig"}).

![Genome-wide effect of ES6S blockage on translation.\
(**a**) Distribution of translational changes induced by VIC--oligo 4 transfection of HEK293T cells. Only mRNAs showing a p-adj \<0.05 between replicas were selected; data are expressed as log2 fold change (FC) of translation efficiency (TE) (4/VIC-4). The tails of the distribution with FC TE \>1 (TE down) and FC TE \<−0.7 (TE up) were selected for further analysis. (**b**) Gene ontology (GO) analysis of the 'TE down' and 'TE up' groups, showing the six terms (biological processes) with the highest significance (p-value) and fold-enrichment (numbers within the bars) (upper panels). The lower panel shows the differential enrichment of the \'TE down\' group in terms of GO-molecular function and GO-molecular component. The under- and over-represented terms are shown. (**c**) Analysis of the 5′ UTR features of mRNAs in TE groups. The length, G+C composition and RNA structure content of 5′ UTRs were analyzed and compared among groups using the Mann-Whitney U test (p-values are shown). (**d**) Differential enrichment in the (GGC/A)~4~ and G4 (G3L~1-12~) motifs found in the 5′ UTR of 'TE down' mRNAs. Data represent the accumulated percentage of mRNAs that show at least one of the indicated motifs (left panel); p-value\<10^−5^ after χ^2^ test. The lower panel shows a box plot of the log~2~ FC TE of mRNAs showing at least one (GGC/A)~4~ motif (left) or one G4 (G3L~1-12~) motif (right) compared with the corresponding subset of mRNA showing no motifs. The p-values generated by U tests are shown. (**e**) Effect of VIC--oligo 4 on the translation of Luc mRNAs bearing the indicated motifs in the 5′ UTR. Translations were carried out in RRL as described in the Materials and methods. Data represent the mean ± SD of six (pLuc and 1x(GGC)~4~) or three (G41, G42 and G43) independent experiments. The calculated stability of the motifs is shown as ΔG° (-kcal.mol^−1^, gray dots); the sequences of the G4 motifs are also indicated (bottom).](elife-48246-fig5){#fig5}

Next, we selected some representative mRNAs from the 'TE down' and 'TE up' groups for validation and further analysis. Among the downregulated mRNAs, we selected CCND3, HRAS, ODC-1, AKT and GRK2, whereas eIF4B and eEF1A1 TOP mRNAs were selected as representatives from the upregulated group. The 'TE down' mRNAs had longer than average 5′ UTRs (188--395 nt) with moderate-to-strong secondary structure, including the presence of G4 or/and (GGC)~4~ motifs ([Figure 6a](#fig6){ref-type="fig"}, left panel). The presence G3- and G2-quadruplexes in the 5′ UTRs of CCND3 and ODC1, respectively, has been reported before to inhibit translation ([@bib29]; [@bib59]). By contrast, representative 'TE up' mRNAs showed shorter than average 5′ UTRs (23 and 63 nt) and lacked the secondary structure typical of 5′ TOP mRNAs ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Thus, most of the 5′ TOP mRNAs detected in our dataset fell within the 'TE up' group ([Figure 6a](#fig6){ref-type="fig"}, right panel). Western blot analysis revealed a dramatic reduction in the accumulation of CCND3, ODC-1, HRas and AKT1 protein upon VIC--oligo 4 transfection, whereas GRK2 protein accumulation was reduced but to a lesser extent ([Figure 6b](#fig6){ref-type="fig"}). Time-course experiments confirmed the high sensitivity of CCND3, followed by AKT1 and HRAS, to VIC--oligo 4 ([Figure 6b](#fig6){ref-type="fig"}, right panel). The short half-life of the CCND3 protein (about 30 min) probably accounts for its rapid disappearance after blockage of de novo synthesis by VIC--oligo 4. However, the accumulation of eIF4B increased slightly in cells transfected with fluorophore-conjugated oligo 4s, especially TR-oligo 4 ([Figure 6c](#fig6){ref-type="fig"}). These results are in good agreement with the data from polysome profiling ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}).

![Effect of VIC--oligo 4 and TR--oligo 4 on the translation of mRNAs representative of the 'TE down' and 'TE up' groups.\
(**a**) 5′ UTR features of the representative mRNAs selected for the analysis, with structure stability per nucleotide shown, as well as the presence of (GGC/A)~4~ and G4s (G~2~L~1--12~ and G~3~L~1--12~) (left panel). The right panel shows a comparative analysis of log~2~ FC TE between all mRNAs and those TOP mRNAs that we detected in our dataset (36). p-value after U test is shown. (**b**) (Left) Western blot of the accumulated proteins at 24 hr post-transfection (hpt) of the indicated oligos in HEK293T cells. (Right) Time course of protein accumulation at 8 hr, 16 hr and 24 hr post-transfection (hpt) of VIC--oligo 4, with data represented as percentage of the control values (+ oligo 4). (**c**) Comparative effect of hippuristanol (hipp), VIC--oligo 4 and TR--oligo 4 on the indicated protein levels. Data were analyzed by western blot at 24 hpt with the indicated oligonucleotides; hipp was used at 1 μM. (**d**) Effect of eS4--EGFP and eS4A--EGFP overexpression on the accumulation of some representative proteins. HEK293T cells were transfected with plasmids expressing the indicated proteins and cell extracts were analyzed by western blot at 48 hpt.](elife-48246-fig6){#fig6}

Translation of CCND3 has been reported to be sensitive to eIF4A inhibition ([@bib60]), so we compared the effects of VIC--oligo 4 and the eIF4A inhibitor hippuristanol (hipp) ([@bib4]). Interestingly, a similar but not identical effect on translation was found ([Figure 6c](#fig6){ref-type="fig"}). Whereas hipp, like VIC--oligo 4, reduced the accumulation of GRK2, AKT1 and CCND3 proteins, HRAS translation was not affected by hipp, and translation of eIF4B mRNA increased upon treatment with hipp, as also observed for TR--oligo 4 ([Figure 6c](#fig6){ref-type="fig"}). These results suggest a partial functional overlap of the ES6S region and helicase eIF4A in the translation of specific mRNAs. To analyze this in more detail, we compared our data set with that published by [@bib36] using human cells, in which the expression of eIF4A was silenced by interference. Notably, translation of these eIF4A-dependent mRNAs was also affected by VIC--oligo 4, and about half of the eIF4A-dependent mRNAs fell into our VIC--oligo-4-sensitive group ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). However, in comparing our data set with the available information on the genome-wide effects of eIF4A inhibition or downregulation, we find that ES6S blockage seems to have a wider impact on translation than eIF4A downregulation ([@bib36]; [@bib48]; [@bib60]).

We also tested the effect of the overexpression of two different eS4--EGFP fusion proteins on the accumulation of some representative proteins. Notably, translation of AKT-1 mRNA was strongly inhibited by eS4--EGFP overexpression, whereas the accumulation of GRK2 and HRAS proteins was less affected. A slight increase in eIF4B protein level was also observed upon transfection of eS4--EGFP ([Figure 6d](#fig6){ref-type="fig"}). This confirmed that ES6S blockage by both VIC--oligo 4 and eS4--EGFP resulted in comparable effects on translation. mRNA threading into the ES6S region makes scanning slower but more processive.

To better understand the influence of the ES6S region on the scanning process, we studied the effect of VIC--oligo 4 on translation in vitro. As observed in transfected cells, the addition of VIC--oligo 4 to rabbit reticulocyte lysates (RRL) drastically inhibited the translation of mRNAs bearing stable RNA stem-loops in their 5′ UTRs. However, for mRNAs with short and unstructured 5′ UTRs (63 nt and G-less), translation was unaffected or even stimulated by VIC--oligo 4 when reactions were measured at end-point times ([Figure 7a](#fig7){ref-type="fig"}). To better understand this, we analyzed the effect of FITC--oligo 4 in real-time translation experiments. Continuous recording of luc activity has been used to measure the time required to detect luc activity (full-translation time, FTT) and its dependence on scanning time ([@bib54]). Thus, FTT increases linearly with 5′ UTR length, as the 48S-PIC requires more time to complete the scanning of the mRNA when a long 5′ is present ([@bib54]). Surprisingly, FITC--oligo 4 accelerated the accumulation of luc activity in the reactions programmed with 5′ UTR G-less mRNA, and to a lesser extent in those programmed with 5′UTR 63 mRNA ([Figure 7b](#fig7){ref-type="fig"}). FITC--oligo 4 reduced the FTT of 5′ UTR G-less mRNA by 2 min, suggesting accelerated scanning ([Figure 7c](#fig7){ref-type="fig"}).

In parallel experiments using highly structured 5′ UTR-SL20 mRNA, the addition of FITC--oligo 4 drastically reduced the accumulation of luc activity at every time point, although the FTT was not significantly altered, suggesting arrest rather than delay of scanning ([Figure 7c](#fig7){ref-type="fig"}). Interestingly, addition of hipp to 5′ UTR-SL20 mRNA delayed the accumulation of luc activity, which followed a differently shaped curve than that observed for FITC--oligo 4 ([Figure 7b](#fig7){ref-type="fig"}). In contrast to the addition of FITC--oligo 4, the addition of hipp increased the FTT by 2 min, suggesting a delay in the scanning process. Thus, the effect of eIF4A inhibition was similar but not identical to that observed for FITC--oligo 4 on mRNAs that have stable structures in their 5′ UTRs.

To further explore the functional links between the ES6S region and eIF4A, we tested the combined effect of VIC--oligo 4 and hipp on the translation of mRNA with stem-loop (5′ UTR-SL30) or G4 (5′ UTR-G4-1). To this end, we used suboptimal concentrations of VIC--oligo 4 that induced a moderate blockage of translation (2--3-fold), in combination with increasing concentrations of hipp. Clearly, the combination of VIC--oligo 4 and 0.3 μM hipp induced a dramatic synergistic inhibition of translation of 5′ UTR-SL30 mRNA (up to 60-fold), whereas the effect on 5′ UTR-G41 translation was less dramatic (12-fold inhibition) ([Figure 7d](#fig7){ref-type="fig"}). These results strongly suggest that the function of eIF4A helicase and the ES6S region converge during the initiation step.

![mRNA threading into the ES6S region slows down scanning but makes it more processive.\
(**a**) Effect of FITC-oligo 4 on the translation of Luc mRNAs with different 5′ UTRs in RRL. Translation mixtures were incubated for 90 min, which represented the endpoint measurement because no further increase in luc activity was detected. Data are represented as the mean ± SD from at least three independent experiments. (**b**) Luc activity accumulation in continuously recording experiments programmed with the indicated mRNAs. Measurements were taken every 3 min: gray line, no oligo; black line, +FITC--oligo 4. Hipp was added to the indicated samples at a concentration of 2 μM (dashed line). (**c**) Estimates of full translation time (FTT) for 5′ UTR G-less and 5′ UTR-SL20 mRNAs, and the effect of FITC--oligo 4 and hipp on FTT. Data from panel (B) were processed as described before ([@bib54]). The determined FTT values were: 5′ UTR G-less = 9.53 min; 5′ UTR G-less+FITC--oligo 4 = 7.89 min; 5′ UTR-SL20 = 17.57 min; 5′ UTR-SL20+FITC--oligo 4 = 17.56 min; 5′ UTR-SL20+hipp = 19.44 min. (**d**) Synergistic inhibitory effect of VIC--oligo 4 and hipp on translation of 5′UTR SL30-Luc and 5′ UTR G4-1-Luc mRNAs in RRL. Translation mixtures were preincubated with 6 μM of VIC--oligo 4 and with increasing concentrations of hipp for 5 min. Then, mRNAs were added and measurements were taken 90 min later; the calculated combination index (CI) for each mRNA is indicated.](elife-48246-fig7){#fig7}

Discussion {#s3}
==========

Here, we present structural, biochemical and functional data supporting a role of the ES6S region in the scanning process, acting as a threading region where mRNA is unwound before entering the classical mRNA channel of the 40S subunit. Rather than a narrow cleft like the decoding groove, the topology of the ES6S region resembles an open channel in which some differences in the accommodation of mRNA molecules are found. The presumed flexibility of ES6S extensions, especially of ES6S^A^ and ES6S^B^, may assist in the placement of mRNAs according to their secondary structure content. These extensions are similar to the tentacle-like structures described recently for some ESs of the 60S subunit, which are involved in the recruitment of MetAP and NatA proteins to 80S ([@bib11]; [@bib23]). Moreover, as eIF4G has been found to contact both ES6S^E^ and ES6S^B^ extensions ([@bib62]), direct participation of eIF4F in the accommodation of the mRNA in the ES6S region seems likely. Three lines of evidence presented here suggest that eIF4A helicase acts on the mRNA in the ES6S region: (1) crosslinking of eIF4A with mRNA was only detected when 4-thio-Us were placed in mRNA positions that fit in the ES6S region of 48S-PIC model; (2) Hipp and VIC--oligo 4 exhibited a strong inhibitory synergy when assayed on 5′ UTR-SL30 mRNA in vitro; and (3) ES6S blockage affected the translation of mRNAs with a 5′ UTR that is enriched in classical dsRNA structures and/or G4s, similar to that previously described when eIF4A activity was inhibited by drugs or silenced ([@bib36]; [@bib48]; [@bib60]). Nonetheless, the exact placement of the eIF4A helicase bound to mRNA in the scanning complex could not yet be mapped, most probably because of the dynamic nature of eIF4A--mRNA interactions. Besides eIF4A, we also detected interaction of eIF3g with mRNA in the ES6S region, which fits well with its binding to eIF3b very close to the ES6S^A^ helix ([@bib7]; [@bib9]). Furthermore, some mutations in the RNA-binding domain of eIF3g have shown decreased processivity of scanning of the structured 5′ UTRs of yeast mRNA ([@bib6]). The possibility that other RNA helicases, such as DDX3, DHX9 and DHX36, could also associate with the ES6S region to unwind dsRNA and G4 structures in mRNA deserves further investigation.

The blocking activity showed by oligo 4 was striking because it was only observed when relatively bulky molecules (such as VIC) were conjugated to its 5′ extreme. Although the exact arrangement of VIC--oligo 4 bound to 40S was not determined, the fluorophores probably project toward the cavity of the ES6S region, at least partially blocking it. However, we cannot rule out the possibility that the binding of VIC--oligo 4 to the target sequence may also restrict the conformational changes that ES6S^A^ and ES6S^B^ helices have been shown to undergo during initiation ([@bib34]; [@bib51]). The differential sensitivity of mRNAs to the translational blockage imposed by VIC--oligo 4 reveals the existence of a great diversity in mRNA-dependence for scanning. Thus, the translation of mRNAs with relatively long and structured 5′ UTRs (like CCND3, H-RAS and ODC-1) was impaired by ES6S blockage, whereas the translation of mRNAs with short and unstructured 5′ UTRs (like many 5′TOP mRNAs) was unaffected or even enhanced by VIC--oligo 4 transfection. This differential effect can be explained if we consider the ES6S region as a true threading path for mRNA that makes the scanning of the 48S-PIC slower but more processive ([Figure 8a](#fig8){ref-type="fig"}). Thus, translation initiation of mRNAs with short and unstructured 5′ UTRs could be enhanced by blocking of ES6S, as PIC recruitment and scanning of these mRNAs does not require unwinding. Under ES6S blockage, these mRNAs could be threaded directly into the classical mRNA channel, bypassing the ES6S region and thus accelerating the scanning process ([Figure 8b](#fig8){ref-type="fig"}). In addition, these mRNAs could also better compete for translational machinery in the context of general shut-off induced by VIC--oligo 4. According to this, participation of the ES6S region in ribosomal attachment to mRNA would be dispensable, at least for some mRNAs with unstructured 5′ UTRs such as 5′ TOP mRNAs, which also show little or no requirement for eIF4A ([@bib12]; [@bib35]). However, whether mRNA is threaded into the ES6S region during ribosomal attachment, or rather is slotted into the ES6S region once the 5′-cap has entered the classical mRNA channel is still an open question that deserves further investigation.

![Model of the scanning 48S-PIC showing the path of mRNA through the ES6S region.\
(**a**) Stem-loop (SL) and G4 (three layer square) represent elements of mRNA secondary structure; core eIF3 and some peripheral subunits (3b/3 g/3i) are shown. For simplicity, only the helicase component (eIF4A) of the eIF4F complex is shown. (**b**) Effect of ES6S blockage on mRNA threading. The model represents an extreme situation upon ES6S blockage that excludes mRNA from the ES6S region. For mRNAs with short and unstructured 5′ UTRs, bypassing the ES6S region could accelerate the scanning process (upper). For scanning-dependent mRNAs with long and structured 5′ UTRs, exclusion from the ES6S region would cause the stacking of secondary structural elements at the mRNA entry channel (shown), dissociation of the 48S-PIC, or even the aberrant threading of folded structures into the decoding groove (not shown).](elife-48246-fig8){#fig8}

For mRNAs that have long and structured 5′ UTRs, ES6S blockage probably reduces the processivity of the scanning complex along the 5′ UTR. The stem-loop and G4 structures in the 5′ UTR of mRNAs that are not effectively unwound in the ES6S region would become stacked at the mRNA entry channel, resulting in stalling and/or dissociation of the 48S-PIC from the mRNA. Even if the 48S-PIC could bypass some stem-loops without unwinding, as previously observed in vitro ([@bib1]), it is not clear whether these aberrant complexes would end up being productive. The DHX29 helicase located at the mRNA entry channel of PIC may also alleviate the eventual stacking of some RNA structures at the mRNA entry channel ([@bib17]), although its involvement in the genome-wide unwinding of stable stem-loops and G4s is unknown.

Finally, our data point out the ES6S region as a novel target for small molecules (oligos and aptamers) that could block the translation of specific mRNA subsets, for example those involved in signal transduction and oncogenesis that show extensive RNA structure in their 5′ UTR. This could represent a more specific alternative to the use of eIF4A inhibitors as anti-cancer drugs ([@bib5]).

Materials and methods {#s4}
=====================

Oligonucleotides and recombinant DNA {#s4-1}
------------------------------------

A complete list of the oligonucleotides used in this work can be found in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. Oligonucleotides were purchased from Sigma except for VIC-conjugated versions, which were purchased from Life technologies. In some in vitro experiments using nuclease-treated RRL (Promega), we used a derivative of oligo 4 with phosphorothioate and 2′O-Met modifications that provided increased stability. Templates for in vitro transcription were generated by PCR using the corresponding oligonucleotides, and the resulting products were purified by the DNA Clean and Concentrator-25 kit (Epigenetics). Firefly luciferase constructs bearing different 5′UTRs were constructed in the pLuc plasmid, derived from pEGFP-N1 (Clontech) by exchanging the EGFP CDS for the luciferase-coding sequence using *BamH*I and *Xba*I sites. The sequences of the 5′UTRs are shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

To construct eS4-EGFP fusion proteins, cDNA of human eS4 mRNA (NM_001007.4) was obtained by reverse transcription of total RNA from HeLa cells using the primer fw-hRPS4X, followed by PCR amplification with primers fw-hRPS4X and rev-hRPS4X. The resulting PCR product was cloned into pEGFP-N1 (Clontech) using *Nhe*I and *Hind*III, resulting in a frame fusion of the two proteins separated by a 23-aa linker (LQDPKLRILQSTVPRARDPPVAT). eS4A--EGFP was constructed by cloning the above PCR product using a similar strategy, but the resulting PCR product was cloned into *Nhe*I and *Pst*I sites, resulting in a shorter linker (LQSTATS).

RNA synthesis and purification {#s4-2}
------------------------------

RNAs were in vitro synthesized using HiScribe T7 Quick (NEB) as described previously ([@bib53]). Where indicated, 4-thio-U and/or 30 μCi \[α-^32^P\]GTP were included in the reaction, and the resulting mRNAs were purified through Chromaspin-30 columns (Clontech). To prepare Luc mRNAs for in vitro translation, mRNA transcripts were capped using the vaccinia capping system (NEB) and purified using the RNA Clean and Concentrator-25 kit (Epigenetics). All of the mRNAs used in this work contained a poly(A) tail of 25 nt.

Cell culture and transfection {#s4-3}
-----------------------------

MEFs, HeLa and HEK293T cells were grown in DMEM supplemented with 10% fetal calf serum. Cells were authenticated by microscopic examination and they were free of mycoplasma contamination. For oligonucleotide transfection, cells were grown in 24-well plates at 60--70% confluency and then transfected with 100 pmol of oligonucleotide using TurboFect (Thermo Fisher Scientific) or Lipotransfectin (NiborLab). Oligonucleotide uptake was monitored using a fluorescence microscope. At the indicated times, cells were fixed for immunofluorescence (IF), infected with the indicated viruses or metabolically labeled with \[^35^S\]-Met/Cys for 1 hr and analyzed as described previously ([@bib56]).

esiRNA-mediated interference {#s4-4}
----------------------------

To silence the expression of eIF4A1 gene, HeLa cells (≈ 5 × 10^4^ growing in 6-well plates) were transfected with 0.6 μg of esiRNA (EHU-11150--1, SIGMA) targeting human eIF4A1 mRNA (NM_001416), using INTEREFERin (PolyPlus) as facilitator. Three days later, the level of eIF4A1 protein was analyzed by WB.

Polysome analysis and profiling {#s4-5}
-------------------------------

Two subconfluent p100 plates of MEF or one plate of HEK293T cells were transfected with the indicated oligonucleotide for 12 hr and lysed in polysome buffer (Tris-HCl 30 mM \[pH 7.5\], 100 mM KCl, 5 mM MgCl~2~, 1 mM DTT, 1% Triton X-100 and 50 μg/ml cycloheximide) for 10 min on ice. After three passages through a 22G needle, cell lysates were clarified by low-speed centrifugation and loaded on a 10--40% sucrose gradient prepared in polysome buffer. Gradients were centrifuged at 35,000 rpm in a SW-40 rotor for 3 hr at 4°C in a Beckman SW40.1 rotor and fractionated from the bottom using an ISCO fractionator coupled to a UV recorder. For protein analysis, fractions were extracted with a methanol-chloroform protocol and analyzed by WB with the indicated antibodies. For RNA analysis, fractions were extracted with phenol, ethanol precipitated and pooled in submonosomal (40S, 48S and 60S), monosomal (80S) and polysomal (\>2 ribosomes per mRNA) fractions.

RNA-seq and data processing {#s4-6}
---------------------------

A total of 12 samples were prepared for sequencing. To track the dilutions made during the construction of RNA-seq libraries, 0.3 μL of 50X Mix 1 dilution of ERCC RNA spike-in mix (Thermo Fisher Scientific Fisher) was added to the samples prior to rRNA depletion. The cDNA libraries were prepared with 1 μg of rRNA-depleted RNA using the TruSeq Stranded mRNA Sample Preparation kit (Illumina, Inc). RNA-seq was carried out on an Illumina HiSeq 2500 platform, and raw data quality control was generated using FastQC. We used the GRCh38 human genome release and Ensembl annotation for further analysis. Bowtie 1.1.2 ([@bib26]) was used with default parameters to remove rRNA reads, to estimate the differential dilution of the samples via the spike-in, and to align RNA reads. About 75% of reads were aligned in each sample. Alignments were refined with Hisat2 2.1.0 ([@bib22]) using the --*known-splicesite-infile* parameter to define the intron limits. Read counting per gene was done with Featurecounts release 1.6.3 ([@bib28]). The library size and spike-in were used to normalize counts using the median of ratios method ([@bib32]). The DESeq2 R package was used to estimate the translation efficiency (TE) of each sample and to compare TE between samples ([@bib32]). We defined TE as the ratio of the mRNA abundance in the polysomal fraction divided by the abundance in the monosomal fraction. Change in TE was calculated as TE~oligo\ 4~/TE~VIC--oligo4~ and expressed in log~2~fold change TE (FC TE). To generate the database with feature annotations for every mRNA, we integrated information from the Ensembl human 95 database with stable RefSeq ID, with Transcript Support Level (TSL) and APRIS annotation. We also incorporated experimental mapping of the +one transcription start site (TSSs) using the nanocage technique that was available for 2500 mRNAs of HEK293T cells ([@bib12]). RNA secondary structures were predicted using the RNAfold 2.2.10 algorithm of the ViennaRNA package ([@bib31]). For the analysis, the minimum folding energy of the centroid structure was used, including G4s or not.

UV crosslinking experiments {#s4-7}
---------------------------

Crosslinking experiments using \[^32^P\]-labeled mRNAs with photoreactive 4-thio-U were carried out as previously described ([@bib51]). 48S or 80S complexes were assembled with GMP-PNP or cycloheximide, respectively, and incubated at 30°C for 20 min. After crosslinking at 360 nm, lysates were centrifuged over a 20% sucrose cushion at 90,000 x g for 3 hr, and the whole ribosomal fraction (WRF) was resuspended in 50 μL of TE buffer. For protein analysis, samples were digested with RNAse A and T1 for 1 hr at 37°C before SDS-PAGE analysis as described previously ([@bib51]).

Mapping mRNA--18S rRNA contacts {#s4-8}
-------------------------------

To identify contacts between mRNA and 18S rRNA within the 48S PIC, a large-scale experiment using 0.5 ml of RRL and cold 4-thio-U labeled mRNAs was carried out. After UV crosslinking at 360 nm, the WRF was denatured in 500 μl buffer D (Tris-HCl 30 mM \[pH 7.5\], 0.5 M LiCl, 0.5% LiDS, 0.5 mM EDTA and 1 mM DTT) and poly(A)+ mRNA was captured with oligo(dT) magnetic beads (NEB) under denaturing conditions. After extensive washing, RNA was eluted with 100 μl H~2~O and concentrated by ethanol precipitation in the presence of glycogen. Captured 18S RNA that was crosslinked to mRNA was analyzed by reverse transcriptase termination site (RTTS) assays as described previously ([@bib21]). Briefly, 18S rRNA was retrotranscribed with Superscript IV (Invitrogen) using 2 pmol of primer 3 followed by a 20 min digestion with RNAse H. The resulting cDNA population was purified with AMPURE beads and 3′ ligated to primer 3′ RTTS_adapter with CirLigase (Illumina). Then, a 30-cycle PCR with oligos 3′\_adapter and RP_FWD was carried out, followed by a final 10-cycle PCR with oligo RP_FWD and oligos RP_REV_INDEX 5, 6, 7 or 12 (see [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The resulting libraries were sequenced in a MiSeq system (Illumina), and reads were aligned to rabbit 18S rRNA with Bowtie 2 using the default parameters. The crosslinking sites in 18S were identified as the 5′-adjacent nucleotide to the 5′ end of every aligned read.

Mapping mRNA--protein contacts {#s4-9}
------------------------------

To identify proteins that crosslinked to unlabeled mRNA in the 48S-PIC, a large-scale experiment using 0.5 ml of RRL and 3 μg of the indicated mRNA were used. After 30 min crosslinking at 254 nm, WRFs were resuspended in buffer D (Tris-HCl 30 mM \[pH 7.5\], 0.5 M LiCl, 0.5% LiDS, 0.5 mM EDTA and 1 mM DTT) and poly(A)+ mRNA was captured with oligo(dT) magnetic beads (NEB) under denaturing conditions as described above. After extensive washing, RNA was eluted with 100 μl H~2~O and digested with RNAse A and T1. Samples were trypsin digested, concentrated and analyzed by high-resolution LC-ESI-MS/MS.

Denaturing immunoprecipitation {#s4-10}
------------------------------

dIP was carried out as described recently ([@bib53]). Briefly, the ribosomal fraction from a 500 μl translation reaction including 2 × 10^6^ cpms of \[α-^32^P\]−4-thio-U-SV-DLP U1 mRNA and 2 mM GMP-PNP was obtained as described previously ([@bib51]). The WRF was obtained as above and denatured in a buffer containing Tris-HCl 50 mM (pH 7.4), 5 mM EDTA, 10 mM DTT and 5% w/v SDS. After 5 min boiling, samples were kept on ice and slowly renatured in Tris-HCl 50 mM (pH 7.4), 150 mM NaCl, 5 mM EDTA, and 1% Triton X-100. Then, the extract was split and incubated with the indicated antibodies overnight at 4°C. Next, a mixture of protein A/G conjugated to magnetic beads (Thermo Fisher Scientific) was added and incubated for 1 hr at room temperature, and immunoprecipitated complexes were analyzed by SDS-PAGE and autoradiography.

Mapping of 3′ oligo 4--18S rRNA pairing {#s4-11}
---------------------------------------

5 pmol of oligo 4 or VIC--oligo 4 were incubated with 30 pmol of 40S subunits purified from RRL and incubated for 30 min at 30°C in polysome buffer. Then, DNA--RNA hybrids were digested with 5 U of RNAse H (NEB) for 15 min at 37°C, extracted with phenol and ethanol precipitated. The 3′ end of the resulting RNA fragments was polyadenylated with poly(A) polymerase (NEB) and retrotranscribed with oligo(dT) primer. Finally, the resulting cDNA was amplified by PCR using oligo(dT) and oligo 9 primers, and sequenced. Data confirmed that the final 6 nt at the 3′ end of oligo 4 remained unpaired, and that the first nt of 18S rRNA that paired with the oligo 4 was C835.

Western blot and immunofluorescence {#s4-12}
-----------------------------------

Western blots were carried out as described previously ([@bib56]) using the following primary antibodies: anti-RPS4X (sc-85133, Santa Cruz Biotech.), anti-RPS7 (sc-377317, Santa Cruz Biotech.), anti-RPS6 (sc-74576, Santa Cruz Biotech.), anti-eIF4A (STJ2724, St. John´s lab,), anti-eIF3g (STJ23512, St. John´s lab), anti-EGFP (11814460001, Roche), anti-eEF1A1 (2551, Cell Signaling), anti-AKT1 (9272, Cell Signaling), anti-ACTB (T-5168, Sigma), anti-eIF4b (sc-376062, Santa Cruz Biotech.), anti-HRas (sc-53959, Santa Cruz Biotech.), anti-CCND3 (sc-453, Santa Cruz Biotech.), anti-ODC1 (sc-398116, Santa Cruz Biotech.), anti-GRK2 (a gift from C. Murga, CBMSO). Blots were developed with ECL (GE) and bands were quantified by densitometry. Immunofluorescence analysis was carried out as described previously using anti-RPS7 (1:500) and anti-mouse Alexa 595 as secondary antibody (Invitrogen). The preparations were analyzed under a Nikon A1R confocal microscope.

Protein and oligonucleotide modeling {#s4-13}
------------------------------------

Models of the human PIC (EMD-5658), 80S (EMD-5326) and rabbit 48S PIC (PDB: 4KZZ) were visualized in Chimera ([@bib44]). Models of eS4--EGFP were generated in Phyre2 ([@bib20]) and I-Tasser ([@bib61]). Both programs rendered models covering 95% of protein length at high confidence (\>90%), showing a root mean square deviation (RMSD) of 0.5--1 Å. The linker was predicted to adopt a random coil conformation, so the resulting models differed somewhat in the relative orientation of the two proteins. eS4--EGFP was modeled into the human 40S subunit (EMD-5326) using the matchmaker command of Chimera with default parameters. Models showing clashes between EGFP and ES6SC-D were discarded.

In vitro translation and luciferase measurement {#s4-14}
-----------------------------------------------

Translations were carried out in 10--15 μl samples containing 70% vol of RRL (Promega) and 50 ng of luciferase mRNA, and reactions were incubated at 30°C for the indicated times. For continuous recording of luc activity, 1 μl samples were taken every 2 min and kept on ice. Luc activity was measured on a Berthold luminometer.
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###### Sequence and secondary structure of the 5′ UTRs used in study.

The predicted secondary structure (RNAfold) is depicted in dot-bracket notation. Stem-loops are marked in red together with the predicted stability (ΔG°). The predicted stability for the entire 5′ UTR is shown, including the correction for 5′ UTR length. For the 5′ UTR of luc mRNAs, shared sequences are in bold.

###### Table of primers.

The sequences of oligonucleotides used for blocking the ES6S region and for PCR amplification are shown.

Data availability {#s7}
=================

GEO accession number: GSE129651.

The following dataset was generated:

IreneDíaz-LópezRenéToribioJuanJosé BerlangaIvánVentoso2019GSE129651NCBI Gene Expression OmnibusGSE129651
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The paper provides a strong mechanistic insight into the mechanism that explains the inverse correlation between mRNA 5\'UTR G+C content/ ΔG and mRNA translation efficiency. It bolsters the model for the function of eIF4A in unwinding the mRNA 5\' secondary structure to facilitate ribosome recruitment. They have documented the role of the ribosomal ES6S region in the control of ribosome scanning. They provide evidence that mRNA is threaded into the ES6S region of 48S pre-initiation complex (PIC), and unwound by the RNA helicase eIF4AI, rendering the 48S PIC more processive, particularly on mRNAs with long and structured 5´UTRs. It would be important in the future to distinguish between the activities of eIF4AI and eIF4AII because the functions of eIF4AI and eIF4AII are were suggested in some studies not to be equivalent.

**Decision letter after peer review:**

Thank you for submitting your article \"An mRNA-threading channel in the ES6S region of the translation 48S-PIC promotes RNA unwinding and scanning\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Nahum Sonenberg as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by a Reviewing Editor and James Manley as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This is an interesting manuscript that explores the role of a specific topological region of the ribosome in translation initiation. The authors performed experiments to interfere with the ES6S region of the 48S-PIC and report that this selectively blocks translation of mRNAs with structured 5\' UTRs. They interpret their data to indicate that mRNAs that thread into this region are scanned slower and in a more processive manner than mRNAs that bypass this region. Overall this is a good study, but there are some weaknesses, including missing controls and interpretation of the experiments. The reviewers raised many important points, that you can see in the full reviews. The concerns listed below are the most critical.

Essential revisions:

1\) Consistent with a previous study, the authors show that 4-thio-U crosslinking identifies an interaction between unstructured and viral mRNA with eIF3g and eIF4A. However, only eIF3g is found to crosslink to this region on the unstructured mRNA, raising a question about how general the position of eIF4A may be on non-viral mRNAs.

2\) A major weakness of the study is that the authors have not directly shown whether the oligo-fluorophore conjugate that is complementary to ES6Sd and EGFP-eS4 actually inhibits the interaction of the mRNA and the ES6S region. All interpretations of the experiments assume this, but this should be directly tested using the 4-thio-U crosslinking experiment in the presence of the oligo and EGFP-eS4.

3\) The authors monitor the rate of luciferase translation in the presence of oligo and hippuristanol in Figure 7. The delay in appearance of LUC protein and the synergistic inhibition is interpreted to mean that scanning rates are slower. This seems a bit of a strong statement for an assay that only monitors the rate of luciferase translation. Without additional evidence that more rigorously tests the rate of \"scanning\", the authors should significantly tone down the interpretation of this experiment (that mRNA threading into the ES6S region makes scanning slower but more processive).

The evidence for mRNA \"threading\" model in this study is not very strong. The claim that eIF4A may function in the ES6S region to unwind duplex regions should be qualified, as the eIF4A crosslink is only studied in the presence of viral mRNAs.

4\) The appropriate control for Figure 3---figure supplement 2B would be VIC-oligo C.

5\) Does GFP tagging of another ribosomal protein yield the same results as eS4-EGFP?

6\) Figure 4A. How do the mRNAs, including HCV IRES respond to VIC-oligo C (the control)? This negative control is missing. The sequences of the 5\' UTRs of the reporters used here are shown as some computer printout in Supplementary file 1 in a few crude ways with no attempt to make this reader-friendly -- this should be corrected. Please confirm that there are no upstream AUGs in any of the reporters used, as this could confound interpretations (by my visual scan there didn\'t appear to be).

7\) The authors do not specify whether the antibody they used for IP in the cross-linking experiments is anti-4AI or 4AII. This was neither done in their previous paper (Toribio et al., 2018). Because the functions of eIF4AI and eIF4AII are not equivalent, it is important to show which eIF4A is studied in this paper, and some discussion about the different functions of 4AI and II would be very informative to the reader.

*Reviewer \#1:*

The paper provides a strong mechanistic insight towards the understanding of the inverse correlation between mRNA 5\'UTR G+C content/ ΔG and mRNA translation efficiency. It provides further support for the function of eIF4A in unwinding the mRNA 5\' secondary structure to facilitate ribosome recruitment. However, it is surprising that the authors have not made use of their excellent experimental system to distinguish between the activities of eIF4AI and eIF4AII. In fact, they do not specify whether the antibody they used for IP in the cross-linking experiments is anti-4AI or 4AII. This was neither done in their previous paper (Toribio et al., 2018). Because the functions of eIF4AI and eIF4AII are not equivalent, it is important to show which eIF4A is studied in this paper, and some discussion about the different functions of 4AI and II would be very informative to the reader.

Figure 4B; It is not immediately clear why the translation of EMCV and poliovirus RNAs is not affected by VIC-Oligo4, inasmuch as the translation of both is eIF4AI dependent.

Figure 5A; The ribosome profile in the polysome region appears abnormal. The experiment must have been repeated, but I could not find how many times this experiment (and several others) was repeated. Could they show a different profile?

*Reviewer \#2:*

In this manuscript, Ventoso and colleagues undertake experiments to interfere with the ES6S region of the 48S-PIC and report that this selectively blocks translation of mRNAs with structured 5\' UTRs. They interpret their data to indicate that mRNAs that thread into this region are scanned slower and in a more processive manner than mRNAs that bypass this region. It\'s an interesting manuscript that explores the role of a specific topological region of the ribosome in translation initiation.

Essential revisions:

\- I believe an appropriate control for Figure 3---figure supplement 2B would be VIC-oligo C.

\- Does GFP tagging of another ribosomal protein yield the same results as eS4-EGFP?

\- Shouldn\'t there be a length control for SL20 in Figure 4A? This is also a good opportunity for the authors to test how systematically increasing structure tracks with translational efficiency using this assay. As well, the analysis of the effect of length on efficiency should be more systematically analyzed here. As it stands, the authors have not taken full advantage of the potential of this assay to strengthen their cause.

\- Figure 4A. How do these mRNAs, including HCV IRES respond to VIC-oligo C (the control)? This negative control is missing. The sequences of the 5\' UTRs of the reporters used here are shown as some computer printout in Supplementary file 1 in a few crude way with no attempts to make this reader-friendly -- this should be corrected. Please confirm that there are no upstream AUGs in any of the reporters used, as this could confound interpretations (by my visual scan there didn\'t appear to be).

\- Figure 4B -- SFV. The panel is not properly mounted. Lane 4 seems to have been prematurely cropped on the right and the top panel is not lined up properly with the bottom ethidium stained control.

Figure 5E -- Are these values standardized to an internal control? How do these reporters respond to VCI-oligo C (negative control).

\- I am sure that the authors know that the Western blots shown in Figure 6 are not reporting on a translational response. Please show distribution of the test mRNAs across polysome gradients or perform metabolic labelled followed by IP to report on nascent protein production.

\- Subsection "Genome-wide analysis reveals the role of the ES6S region in translation of mRNAs with G-rich 5´UTRs". The Rubio and Wolfe studies using rocaglates probably should not be cited here since these cause clamping of 4A to RNA, hence they do not lead to only a loss of 4A activity since the clamped complexes themselves can interfere with translation (see PMID 27309803).

\- Do all constructs yield the same final levels of Luciferase in the FTT assay? Why is the area under the curves in Figure 7c between the two conditions very different? Is this reflective of more/less mRNA being translated? Where is the FITC-oligo C control?

\- I am not sure how to interpret Figure 7D. The authors indicate that they utilize suboptimal concentrations of VIC-oligo-4 to induce a moderate block of translation (2-3 fold). Since to get an effect of VIC-oligo4 you only need one oligo bound to the ribosomal target, it means there is a pool of ribosomes that are also not bound by the oligo. I am not sure what exactly the \"synergy obtained with hipp means -- does it mean synergistic effects with those ribosomes having a bound VIC-oligo-4, or does it mean hipp is acting on those ribosomes not having a VIC-oligo 4 bound and exerting an effect unrelated to the ES6S region and this is being \"scored\" as a synergistic effect. Where are the controls with VIC-oligo C.

\- The authors refer to the synthetic 128-nt mRNA as \"flat\". This is somewhat vernacular and the authors might want to change this to a more scientifically appropriate label.

\- Subsection "The path of mRNA through the ES6S region of the 48S PIC". The authors write \"According to our data, eIF4A may be placed a bit further downstream, probably between the ES6SA 179 and ES6SB 180 helices (Figure 2C).\" I don\'t see in Figure 2c, where the ES6SA and ES6SB sites are indicated.

*Reviewer \#3:*

The authors have two major findings that could potentially transform our understanding of mRNA recruitment.

Firstly, the authors have shown that 4-thio-U crosslinking of the +24 to +34 region of an mRNA occurs around the ES6S region of the 40S subunit (within the 48S PIC). This is obtained using a short unstructured mRNA and GMP-PNP. Consistent with this, non-specific UV crosslinking also reveals interactions between the mRNA and eS4/uS4, which is generally consistent with the ES6S interaction region. Consistent with a previous study, the authors show that 4-thio-U crosslinking identifies an interaction between unstructured and viral mRNA with eIF3g and eIF4A. This crosslinking occurs in the same mRNA region that crosslinks to the ES6S region suggesting that eIF3g and eIF4A are located in this area in the 48S PIC. However, only eIF3g is found to crosslink to this region on the unstructured mRNA, raising a question about how general the position of eIF4A may be on non-viral mRNAs.

The second major finding is that perturbation of the ES6S region, either by an oligo-fluorophore conjugate that is complementary to ES6Sd or by an EGFP fused eS4 protein (located near ES6S), leads to reduced translation rates. This is shown using reporter mRNAs as well as on a genome wide scale. Interestingly, inhibition of translation is evident on mRNAs harboring highly structured and/or long 5\'UTRs (including G quadruplex containing 5\'UTRs). The specificity of inhibition is controlled for by using the same oligo without the fluorophore or to an oligo that is complementary to a different rRNA region.

The main weakness of the study is that the authors have not directly shown whether the oligo conjugate and EGFP-eS4 actually inhibits the interaction of the mRNA and the ES6S region. All interpretations of the experiments assume this, but this should be directly tested using the 4-thio-U crosslinking experiment in the presence of the oligo and EGFP-eS4.

The authors monitor rate of luciferase translation in the presence of oligo and hippuristanol in Figure 7. The delay in appearance of LUC protein and the synergistic inhibition is interpreted to mean that scanning rates are slower. This seems a bit of a strong statement for an assay that only monitors the rate of luciferase translation. Without additional evidence that more rigorously tests the rate of \"scanning\", the authors should significantly tone down the interpretation of this experiment (that mRNA threading into the ES6S region makes scanning slower but more processive).

This reviewer doesn\'t really see strong evidence for mRNA \"threading\" model from this study. The claim that eIF4A may function at the ES6S region to unwind duplex regions also seems over interpreted -- as far as I can see, the eIF4A crosslink only seems to occur in the presence of viral mRNAs.

Overall this is an interesting study, but some major weaknesses with interpretation of the experiments does lower enthusiasm somewhat.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"An mRNA-binding channel in the ES6S region of the translation 48S-PIC promotes RNA unwinding and scanning\" for further consideration at *eLife*. Your revised article has been favorably evaluated by James Manley (Senior Editor), a Reviewing Editor, and one reviewer.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below: There is one concern that was not adequately addressed. The authors state in their rebuttal that the St. John lab antibody is against eIF4AI according to the company\'s datasheet.

\"The antibody used here and in previous papers to detect eIF4A by IP experiments was STJ27247 from St. John\'s lab. According to the datasheet provided by the supplier, the antibody was raised in rabbits using the amino acids 1-406 aa of eIF4AI as immunogen, so that we assume it is specific for eIF4AI. A single protein band was detected by western blot using this antibody, suggesting that the antibody does not react with eIF4AII.\"

However, the authors need to demonstrate that the antibody is specific to eIF4AI. Also, this information is not presented in the material and methods section and they keep refereeing to eIF4A throughout the paper.

It is important to address this issue because the existing confusing literature that claims that eIF4AII exhibits an antagonistic function to eIF4AI muddles the literature. The authors should alert the readers to this.

10.7554/eLife.48246.sa2

Author response

> Reviewer \#1:
>
> The paper provides a strong mechanistic insight towards the understanding of the inverse correlation between mRNA 5\'UTR G+C content/ ΔG and mRNA translation efficiency \[...\] This was neither done in their previous paper (Toribio et al., 2018). Because the functions of eIF4AI and eIF4AII are not equivalent, it is important to show which eIF4A is studied in this paper, and some discussion about the different functions of 4AI and II would be very informative to the reader.

The antibody used here and in previous papers to detect eIF4A by IP experiments was STJ27247 from St. John´s lab. According to the data sheet provided by the supplier, the antibody was raised in rabbits using the amino acids 1-406 aa of eIF4AI as immunogen, so that we assume it is specific for eIF4AI. A single protein band was detected by western blot using this antibody, suggesting that the antibody does not react with eIF4AII.

We agree with the reviewer that our system would be an excellent opportunity to test in the future whether eIF4AII could also bind ES6S region of 48S-PIC, a finding that could provide further insights into the mechanism of miRNA-mediated translational arrest.

> Figure 4B; It is not immediately clear why the translation of EMCV and poliovirus RNAs is not affected by VIC-Oligo4, inasmuch as the translation of both is eIF4AI dependent.

Our data consistently showed that translation driven by EMCV and PV IRES was unaffected, or only marginally affected by VIC-oligo 4. As the reviewer points out, eIF4AI binds the EMCV and PV IRES (together with eIF4G and other proteins) to actively prepare the mRNA for 43S-PIC attachment. Importantly, this \"activation\" step occurs before ribosomal attachment so that it would not be affected by the presence of VIC-oligo 4. Since EMC and PV mRNAs do not require scanning (or a minimal scanning for PV mRNA), translation of these mRNAs would be largely independent of ES6S-associated unwinding activity of eIF4A that promotes scanning.

> Figure 5A; The ribosome profile in the polysome region appears abnormal. The experiment must have been repeated, but I could not find how many times this experiment (and several others) was repeated. Could they show a different profile?

Figure 5A shows the polysome profile corresponding to exp \#1 intended to RNAseq. analysis. This profile can be considered as representative of what we routinely found in HEK293T cells using our protocols. The presence of intact large polysomes in heavy fractions was confirmed by WB with anti-S6 antibodies (lower panel Figure 5---figure supplement 1A). This polysome profile is very similar to the one shown in Figure 3B,

> Reviewer \#2:
>
> \[...\] Essential revisions:
>
> \- I believe an appropriate control for Figure 3---figure supplement 2B would be VIC-oligo C.

Wherever possible, we included more than one control oligo in our experiments. The effect of VIC-oligo C was extensively tested, giving similar results to oligo 4 alone (no effect). A new panel (c) in Figure 3---figure supplement 3 comparing the effect of oligo 4, VIC-oligo C and VIC-oligo 4 on translation in MEFs is now included.

> \- Does GFP tagging of another ribosomal protein yield the same results as eS4-EGFP?

We initially selected two ribosomal proteins surrounding the ES6S region as candidates for GFP tagging: eS4 and eS7. Unfortunately, eS7-GFP fusion accumulated at very low levels in transfected cells and it hardly incorporated into the 40S subunit (results not shown). Due to design limitations, we have not explored any further RPSs for GFP tagging.However, tagging RPSs does not necessarily affect translation as demonstrated using the Halo Tag technology for tagging RACK1 or RPS9 with a protein similar in mass to EGFP (Gallo et al., 2011).

> \- Shouldn\'t there be a length control for SL20 in Figure 4A? This is also a good opportunity for the authors to test how systematically increasing structure tracks with translational efficiency using this assay. As well, the analysis of the effect of length on efficiency should be more systematically analyzed here. As it stands, the authors have not taken full advantage of the potential of this assay to strengthen their cause.

The 5´UTR-85 or G-less mRNAs are similar in length to SL20 and they could be used as length controls. We have constructed two additional mRNAs bearing 5´UTR of intermediate length (242 and 427 nts). These mRNAs, together with those bearing 5´UTR of 33 and 656 nts, were tested in a new experiment similar to that described in Figure 4A. As new panel (a) of Figure 4---figure supplement 1 shows, the sensitivity to VIC-oligo 4-mediated translational block increased with 5´UTR length of mRNA as expected.

> \- Figure 4A. How do these mRNAs, including HCV IRES respond to VIC-oligo C (the control)? This negative control is missing. The sequences of the 5\' UTRs of the reporters used here are shown as some computer printout in Supplementary file 1 in a few crude way with no attempts to make this reader-friendly -- this should be corrected. Please confirm that there are no upstream AUGs in any of the reporters used, as this could confound interpretations (by my visual scan there didn\'t appear to be).

We have now included the effect of VIC-oligo C on translation of some reporter mRNAs, including the HCV IRES. The new information is in panel (b) of Figure 4---figure supplement 1.

Regarding the information provided in Supplemental file 1, we confirm that none of the 5´UTRs used here contain upstream AUGs. The sequences are displayed in the output style from Vienna RNA fold server (courier font) that we used for RNA folding predictions. This is an appropriate plain text to line up sequences according to their length.

> \- Figure 4B -- SFV. The panel is not properly mounted. Lane 4 seems to have been prematurely cropped on the right and the top panel is not lined up properly with the bottom ethidium stained control.

The reviewer is right, and the panel has now been properly lined up.

> Figure 5E -- Are these values standardized to an internal control? How do these reporters respond to VCI-oligo C (negative control).

In these experiments, RRL were programmed with the indicated reporter mRNA alone or in the presence of oligo 4 or VIC-oligo 4. Oligo 4 did not significantly affect translation and these numbers were taken as control. Given the high degree of reproducibility of the results, we did not consider it necessary to include an internal control mRNA. We did not include the VIC-oligo C as control in these experiments.

> \- I am sure that the authors know that the Western blots shown in Figure 6 are not reporting on a translational response. Please show distribution of the test mRNAs across polysome gradients or perform metabolic labelled followed by IP to report on nascent protein production.

The reviewer is right that western blots does not necessarily report a differential translational response, so that we also included the distribution of representative mRNAs in the monosomal and polysomal fractions (expressed as translation efficiency (TE; poly/mono), together with the changes in \"total\" mRNA (RNA) in panel (a) of Figure 6---figure supplement 2. As can be seen, these data were consistent with those shown in Figure 6, so that in this case the western blot can be considered as an appropriate read-out of differential translational response.

> \- Subsection "Genome-wide analysis reveals the role of the ES6S region in translation of mRNAs with G-rich 5´UTRs". The Rubio and Wolfe studies using rocaglates probably should not be cited here since these cause clamping of 4A to RNA, hence they do not lead to only a loss of 4A activity since the clamped complexes themselves can interfere with translation (see PMID 27309803).

The cited references (Rubio et al., 2014 and Wolf et al., 2014) used silvestrol, but not rocaglates.

> \- Do all constructs yield the same final levels of Luciferase in the FTT assay? Why is the area under the curves in Figure 7c between the two conditions very different? Is this reflective of more/less mRNA being translated? Where is the FITC-oligo C control?

No, the final levels of luciferase activity varied among the constructs tested as expected. Thus, 5´UTR G-less yielded higher levels of luciferase activity than 5´UTR SL20 as it is shown in panel a of Figure 7. As the reviewer points out, the area under the curves reflects the differences in translation efficiency among mRNAs.

> \- I am not sure how to interpret Figure 7D. The authors indicate that they utilize suboptimal concentrations of VIC-oligo-4 to induce a moderate block of translation (2-3 fold). Since to get an effect of VIC-oligo4 you only need one oligo bound to the ribosomal target, it means there is a pool of ribosomes that are also not bound by the oligo. I am not sure what exactly the \"synergy obtained with hipp means -- does it mean synergistic effects with those ribosomes having a bound VIC-oligo-4, or does it mean hipp is acting on those ribosomes not having a VIC-oligo 4 bound and exerting an effect unrelated to the ES6S region and this is being \"scored\" as a synergistic effect. Where are the controls with VIC-oligo C.

We empirically titrated the amount of VIC-oligo 4 to find a concentration that induced a moderate block (less than three-fold) in translation. Although the binding of VIC-oligo 4 to ribosome should follow a 1:1 stoichiometry, we now know that in our in vitro assays not all the ribosomes were bound to VIC-oligo 4 even at saturating concentration of this oligo. When we combined VIC-oligo 4 and hipp, the dramatic synergistic effect found obviously corresponded to those 48S PIC having bound VIC-oligo and hipp. If not, a simple additive (but not synergistic) effect would be expected. However, we cannot rule out that some of this additive effect can also contribute to the final effect of VIC-oligo 4+ hipp.

> -The authors refer to the synthetic 128-nt mRNA as \"flat\". This is somewhat vernacular and the authors might want to change this to a more scientifically appropriate label.

The reviewer is right that \"flat\" sounds a bit atypical, so that we have changed it for \"unstructured\" throughout the text.

> \- Subsection "The path of mRNA through the ES6S region of the 48S PIC". The authors write \"According to our data, eIF4A may be placed a bit further downstream, probably between the ES6SA 179 and ES6SB 180 helices (Figure 2C).\" I don\'t see in Figure 2C, where the ES6SA and ES6SB sites are indicated.

The positions of ES6SA and ES6SB helices are now indicated in Figure 2C.

> Reviewer \#3:
>
> The authors have two major findings that could potentially transform our understanding of mRNA recruitment.
>
> Firstly, the authors have shown that 4-thio-U crosslinking of the +24 to +34 region of an mRNA occurs around the ES6S region of the 40S subunit (within the 48S PIC). This is obtained using a short unstructured mRNA and GMP-PNP. Consistent with this, non-specific UV crosslinking also reveals interactions between the mRNA and eS4/uS4, which is generally consistent with the ES6S interaction region. Consistent with a previous study, the authors show that 4-thio-U crosslinking identifies an interaction between unstructured and viral mRNA with eIF3g and eIF4A. This crosslinking occurs in the same mRNA region that crosslinks to the ES6S region suggesting that eIF3g and eIF4A are located in this area in the 48S PIC. However, only eIF3g is found to crosslink to this region on the unstructured mRNA, raising a question about how general the position of eIF4A may be on non-viral mRNAs.

We previously found that eIF4A crosslinking with mRNA was only detected on mRNAs bearing a stable SL within the 25-35 nt stretch downstream the AUGi, suggesting that the presence of stable SL jams eIF4A´s helicase activity, allowing the snapshot of eIF4A-mRNA interaction. No eIF4A crosslinking was detected when SL of mRNA was removed, or when experiments were programmed with unstructured (flat) mRNA, suggesting that the presence of stable structures downstream the AUG, rather the viral or non-viral origin of mRNAs, allowed the detection of eIF4A-RNA interaction. Thus, a pattern of protein crosslinking similar to that found with SV and SFV DLP mRNAs was detected when an mRNA based on β-globin was used (Toribio et al., 2018, Figure S1).

> The second major finding is that perturbation of the ES6S region, either by an oligo-fluorophore conjugate that is complementary to ES6Sd or by an EGFP fused eS4 protein (located near ES6S), leads to reduced translation rates. This is shown using reporter mRNAs as well as on a genome wide scale. Interestingly, inhibition of translation is evident on mRNAs harboring highly structured and/or long 5\'UTRs (including G quadruplex containing 5\'UTRs). The specificity of inhibition is controlled for by using the same oligo without the fluorophore or to an oligo that is complementary to a different rRNA region.
>
> The main weakness of the study is that the authors have not directly shown whether the oligo conjugate and EGFP-eS4 actually inhibits the interaction of the mRNA and the ES6S region. All interpretations of the experiments assume this, but this should be directly tested using the 4-thio-U crosslinking experiment in the presence of the oligo and EGFP-eS4.

To confirm that VIC-oligo 4 perturbs the interaction of mRNA with ES6S region, we carried out crosslinking experiments in the presence of VIC-oligo 4.As shown now in panel (b) of Figure 3---figure supplement 4, the presence of VIC-oligo 4 drastically reduced the crosslinking of eIF3g/eIF4A bands on both SFV DLP and unstructured mRNAs. Interestingly, we found that formation of 48S complex on both mRNAs was enhanced by blocking ES6S with VIC-oligo 4, a finding that is fully consistent with data shown in Figure 7. This result not only confirms that mRNA interacts with elements of ES6S region, but also that ES6S blocking accelerates the formation of 48S complex on mRNAs with unstructured 5´UTR.

> The authors monitor rate of luciferase translation in the presence of oligo and hippuristanol in Figure 7. The delay in appearance of LUC protein and the synergistic inhibition is interpreted to mean that scanning rates are slower. This seems a bit of a strong statement for an assay that only monitors the rate of luciferase translation. Without additional evidence that more rigorously tests the rate of \"scanning\", the authors should significantly tone down the interpretation of this experiment (that mRNA threading into the ES6S region makes scanning slower but more processive).
>
> This reviewer doesn\'t really see strong evidence for mRNA \"threading\" model from this study. The claim that eIF4A may function at the ES6S region to unwind duplex regions also seems over interpreted -- as far as I can see, the eIF4A crosslink only seems to occur in the presence of viral mRNAs.

The statement that mRNA threading into the ES6S region makes scanning slower but more processive is based not only on results fromin vitro FTT experiments, but also on data using reporter mRNAs with 5´UTR of different lengths and genome-wide polysome profiling. In our opinion, the mRNA threading concept is the simplest and most plausible explanation to the results described here. The new data included in Figure 3---figure supplement 4 further supports this idea. Anyway, to be more conservative, we replaced the term threading for binding in the title and in the summary of the manuscript.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below: There is one concern that was not adequately addressed. The authors state in their rebuttal that the St. John lab antibody is against eIF4AI according to the company\'s datasheet. \[...\]
>
> However, the authors need to demonstrate that the antibody is specific to eIF4AI. Also, this information is not presented in the material and methods section and they keep refereeing to eIF4A throughout the paper.
>
> It is important to address this issue because the existing confusing literature that claims that eIF4AII exhibits an antagonistic function to eIF4AI muddles the literature. The authors should alert the readers to this.

To clear up doubts about the specificity of the eIF4A1 antibody used in our manuscript (STJ27247 from St. John\'s lab), we have silenced the expression of human eIF4A1 gene in HeLa cells. A permanent silencing using lentivirus expressing shRNAs was impossible in our hands, probably because eIF4A1 is essential for cell proliferation. So, we carried out a transient silencing by means of esiRNA specific for human eIF4A1 mRNA, and the resulting cell extracts were probed with the antibody cited above. As shown in the new panel b of Figure 2---figure supplement 1, a reduction in the intensity of the 48 kDa protein band was observed, being consistent with the observed transfection efficiency (60-70%). This result shows that STJ27247 antibody is specific for eIF4A1. We have modified the text (figure legend of figure supplement and Materials and methods section) accordingly.

[^1]: Centro de Biotecnología y Genómica de Plantas, Madrid, Spain.
